Go Pro
→ Trump's gold order: the announcement they won't put on the front page (From Reagan Gold Group) (Ad)tc pixel
LON:GENI

GENinCode Final Earnings Report

GENinCode logo
GBX 0.76 -0.04 (-5.50%)
As of 07:03 AM Eastern
ProfileEarnings History

GENinCode EPS Results

Actual EPS
-GBX 2.53
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GENinCode Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GENinCode Announcement Details

Quarter
Final
Date
6/4/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

GENinCode Earnings Headlines

GENinCode Shareholders Approve All Resolutions at Annual General Meeting
July 1, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/genincode-shareholders-approve-all-resolutions-at-annual-general-meeting?utm_source=marketbeat.com&utm_medium=referral
AIM Market Roundup: Marechale Capital, Genincode, Boohoo
June 5, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/aim-market-roundup-marechale-capital-153929945.html
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in 50 years - and it has nothing to do with a single stock. According to multiple Wall Street banks, a coming crisis could keep your portfolio in the red for 10 years or longer. Keith Kaplan, CEO of TradeSmith, is sharing what you can do to protect your wealth before it hits.tc pixel
July 17 at 1:00 AM  |  TradeSmith (Ad)
GENinCode slumps after it reprices options
May 7, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/genincode-slumps-reprices-options-101000125.html
AIM Market Roundup: Phoenix Copper, Pipehawk, Genincode
February 25, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/aim-market-roundup-phoenix-copper-170020859.html
GENinCode Raises £4.1m Following Completion of WRAP Retail Offer
January 26, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/genincode-raises-4-1m-following-completion-of-wrap-retail-offer?utm_source=marketbeat.com&utm_medium=referral
See More GENinCode Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GENinCode? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GENinCode and other key companies, straight to your email.

About GENinCode

GENinCode (LON:GENI) is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide. GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U. GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.

View GENinCode Profile
Earnings Tools